Brain energy and oxygen metabolism: emerging role in normal function and disease

ME Watts, R Pocock, C Claudianos - Frontiers in molecular …, 2018 - frontiersin.org
Dynamic metabolic changes occurring in neurons are critically important in directing brain
plasticity and cognitive function. In other tissue types, disruptions to metabolism and the …

Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview

E Mariani, MC Polidori, A Cherubini… - Journal of Chromatography …, 2005 - Elsevier
According to the free radical theory, aging can be considered as a progressive, inevitable
process partially related to the accumulation of oxidative damage into biomolecules–nucleic …

Delivery of bioactive molecules to mitochondria in vivo

RAJ Smith, CM Porteous, AM Gane… - Proceedings of the …, 2003 - National Acad Sciences
Mitochondrial dysfunction contributes to many human degenerative diseases but specific
treatments are hampered by the difficulty of delivering bioactive molecules to mitochondria …

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

M Chen, VO Ona, M Li, RJ Ferrante, KB Fink, S Zhu… - Nature medicine, 2000 - nature.com
Huntington disease is an autosomal dominant neurodegenerative disease with no effective
treatment. Minocycline is a tetracycline derivative with proven safety. After ischemia …

Coupling endoplasmic reticulum stress to the cell death program

RV Rao, HM Ellerby, DE Bredesen - Cell Death & Differentiation, 2004 - nature.com
The endoplasmic reticulum (ER) regulates protein synthesis, protein folding and trafficking,
cellular responses to stress and intracellular calcium (Ca 2+) levels. Alterations in Ca 2+ …

Oxidatively modified proteins in aging and disease

MF Beal - Free Radical Biology and Medicine, 2002 - Elsevier
There is a large body of evidence implicating oxidative damage in the pathogenesis of both
normal aging and neurodegenerative diseases. Oxidative damage to proteins has been well …

Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice

RJ Ferrante, JK Kubilus, J Lee, H Ryu… - Journal of …, 2003 - Soc Neuroscience
The precise cause of neuronal death in Huntington's disease (HD) is unknown. Although no
single specific protein-protein interaction of mutant huntingtin has emerged as the …

[HTML][HTML] Glyphosate, pathways to modern diseases III: Manganese, neurological diseases, and associated pathologies

A Samsel, S Seneff - Surgical neurology international, 2015 - ncbi.nlm.nih.gov
Manganese (Mn) is an often overlooked but important nutrient, required in small amounts for
multiple essential functions in the body. A recent study on cows fed genetically modified …

Mitochondrial dysfunction in Huntington's disease

C Carmo, L Naia, C Lopes, AC Rego - Polyglutamine disorders, 2018 - Springer
Mitochondrial dysfunction has been described as an early pathological mechanism
delineating the selective neurodegeneration that occurs in Huntington's disease (HD), a …

Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease

J Kim, JP Moody, CK Edgerly, OL Bordiuk… - Human molecular …, 2010 - academic.oup.com
Although a direct causative pathway from the gene mutation to the selective neostriatal
neurodegeneration remains unclear in Huntington's disease (HD), one putative pathological …